Office of Education and Faculty Affairs, Memorial Sloan Kettering Cancer Center (MSK), New York, NY, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
J Cancer Educ. 2023 Aug;38(4):1187-1192. doi: 10.1007/s13187-022-02247-8. Epub 2023 Jan 13.
Diversifying the future cancer research workforce requires that students engage in cancer research, persist in paths toward science, technology, engineering, mathematics, and medicine (STEMM) fields, and choose cancer research careers. The Summer Clinical Oncology Research Experience (SCORE) Program at Memorial Sloan Kettering, designed in 2010 to engage undergraduate (U) and post-baccalaureate (PB) students from diverse backgrounds in cancer research, is an 8-week summer program pairing an U or PB student with a faculty mentor to conduct cancer research. We report demographics and career paths for 2010-2019 SCORE students. Of 116 students, 112 (97%) attended public universities, and 75 (64%) were in their first 2 years of college. Race/ethnicity was Black/African American, 20 (17%); Hispanic/Latinx, 15 (13%); multiracial, five (4%); Asian, 40 (34%); White/Caucasian, 36 (31%). A total of 112 (97%) identified as female; 47 (41%) were first-generation college students, and 85 (73%) were from immigrant families. As of 2021, 114 (98%) persisted in paths toward STEMM careers: 44 (38%) medical school (MS) students, 14 (12%) residents, two (2%) practicing physicians, 12 (10%) pursuing non-MD STEMM advanced degrees, 21 (18%) working in non-MD STEMM fields, 17 (15%) applying to MS, and 4 (3%) U science majors. Cancer research participation significantly increased from 5% pre- to 84% post-SCORE. A total of 63/116 (54%) students subsequently co-authored 152 peer-reviewed publications, including 105 (69%) in oncology. SCORE engaged underrepresented U and PB students in cancer research, and 98% of these students persisted in paths toward STEMM careers. Long-term follow-up is needed to assess the enduring engagement of these underrepresented students in cancer research.
多样化未来癌症研究人员队伍需要学生参与癌症研究,坚持科学、技术、工程、数学和医学(STEMM)领域的道路,并选择癌症研究职业。纪念斯隆凯特琳癌症中心(Memorial Sloan Kettering)的暑期临床肿瘤学研究经验(SCORE)计划于 2010 年设计,旨在让来自不同背景的本科生(U)和大学生后(PB)学生参与癌症研究,这是一个为期 8 周的暑期计划,将 U 或 PB 学生与一名教师导师配对进行癌症研究。我们报告了 2010 年至 2019 年 SCORE 学生的人口统计学和职业道路。在 116 名学生中,112 名(97%)就读于公立大学,75 名(64%)处于大学前两年。种族/族裔为黑人/非裔美国人,20 人(17%);西班牙裔/拉丁裔,15 人(13%);多种族,5 人(4%);亚洲人,40 人(34%);白种人/高加索人,36 人(31%)。共有 112 名(97%)学生自认为是女性;47 名(41%)是第一代大学生,85 名(73%)来自移民家庭。截至 2021 年,114 名(98%)学生坚持 STEMM 职业道路:44 名(38%)医学生,14 名(12%)住院医师,2 名(2%)执业医师,12 名(10%)攻读非医学 STEMM 高级学位,21 名(18%)在非医学 STEMM 领域工作,17 名(15%)申请医学硕士,4 名(3%)U 科学专业。癌症研究参与率从 SCORE 前的 5%显著增加到 84%。共有 63/116(54%)名学生随后共同撰写了 152 篇同行评议出版物,其中 105 篇(69%)发表在肿瘤学领域。SCORE 让代表性不足的 U 和 PB 学生参与癌症研究,其中 98%的学生坚持 STEMM 职业道路。需要进行长期随访以评估这些代表性不足的学生在癌症研究中的持久参与度。